By exploring these chemical modulators and developing novel inhibitors that specifically target MICU2, we could uncover new mechanisms for controlling mitochondrial calcium uptake, potentially leading to effective interventions against CRC and other malignancies where mitochondrial calcium homeostasis plays a critical role in tumor progression. This evidence concerns the gene MICU2 and colorectal carcinoma.